0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2008;300(5):475. doi:10.1001/jama.300.5.475.
Text Size: A A A
Published online

HIV/AIDS

A JAMA THEME ISSUE

Edited by Jeanette M. Smith, MD, and Gianna Zuccotti, MD, MPH

GROWTH HORMONE IN HIV-ASSOCIATED OBESITY

Antiretroviral therapy can be associated with visceral adiposity and metabolic complications, possibly caused by growth hormone (GH) deficiency. In a randomized trial, Lo and colleagues assessed the effects of low-dose GH vs placebo on body composition and cardiovascular disease markers among patients with HIV-associated abdominal obesity. The authors found that patients receiving GH experienced significant reductions in visceral fat, truncal obesity, triglycerides, and diastolic blood pressure but experienced an increase in 2-hour postchallenge glucose levels.

ESTIMATION OF HIV INCIDENCE IN THE UNITED STATES

To assess the incidence of HIV infection in the United States, Hall and colleagues applied an algorithm that combines HIV-antibody testing and the BED HIV-1 capture enzyme immunoassay—which distinguishes recent from long-standing infections—to serum specimens from patients 13 years or older, who resided in 22 states and who were diagnosed in 2006. The authors estimate that there were 56 300 (95% confidence interval, 48 200-64 500) new HIV infections in 2006, which were disproportionately concentrated among men who have sex with men and among African Americans.

EFFECTS OF ANTIRETROVIRAL AND ANTI-TB THERAPY

Rifampicin-based antitubercular therapy reduces plasma concentrations of nevirapine and efavirenz. Few studies have addressed the virological consequences of this effect. In an analysis of prospective clinical data from South African patients with and without concurrent tuberculosis (TB) who initiated antiretroviral therapy (ART) that was either efavirenz-based or nevirapine-based, Boulle and colleagues found that coadministration of rifampicin-based antitubercular therapy at initiation of ART was associated with higher probabilities of a raised viral load or virological failure in the first 2 years of therapy among patients taking nevirapine-based ART but not in patients who initiated treatment with an efavirenz-based treatment.

RISK FACTORS FOR RECENT HIV INFECTION IN UGANDA

To assess demographic, biological, and behavioral risk factors for recent HIV infection in Uganda, Mermin and colleagues analyzed data from the Uganda HIV/AIDS Sero-Behavioral Survey, a nationally representative household survey of Ugandan men and women aged 15 to 59 years. Among the factors found to be associated with a recent HIV infection were female sex, marital status, geographic region, 2 or more sex partners in the past year, positive herpes simplex virus type 2 serology, a sexually transmitted disease in the past year, and being an uncircumcised man.

HAART IN HIV-INFECTED INJECTION DRUG USERS

Some studies have suggested that HIV-infected injection drug users derive less benefit from highly active antiretroviral therapy (HAART) than patients without a history of injection drug use. In a population-based prospective cohort study of antiretroviral-naive HIV-infected patients who had access to free HIV/AIDS care, Wood and colleagues assessed survival rates for patients after initiation of HAART. The authors found no significant difference in mortality rates for users than for nonusers of injection drugs.

CLINICIAN'S CORNER
ANTIRETROVIRAL TREATMENT OF ADULT HIV INFECTION

The International AIDS Society–USA 2008 recommendations for the use of antiretroviral therapy and laboratory monitoring in adult HIV infection.

A PIECE OF MY MIND

“I had lectured patient after patient on how important it is ‘to know for sure.’ The reality is much different when the patient is you.” From “A Person of Status.”

MEDICAL NEWS & PERSPECTIVES

Health leaders are sounding a warning about the global threat posed by a collision between multidrug-resistant tuberculosis and HIV infection.

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

The Mississippi State Department of Health

COMMENTARIES

Mexico's evolving HIV epidemic

Universal access to treatment for HIV infection

Disclosure and assent for research in pediatric HIV infection

Criminalization of HIV transmission

EDITORIAL

The past, present, and future of HIV/AIDS

JAMA PATIENT PAGE

For your patients: HIV infection: the basics

Figures

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

The Mississippi State Department of Health

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.